Structure

Physi-Chem Properties

Molecular Weight:  696.21
Volume:  674.633
LogP:  2.825
LogD:  1.064
LogS:  -2.95
# Rotatable Bonds:  16
TPSA:  246.81
# H-Bond Aceptor:  15
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.059
Synthetic Accessibility Score:  4.372
Fsp3:  0.314
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.194
MDCK Permeability:  4.956887096341234e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.947
Human Intestinal Absorption (HIA):  0.945
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  98.09915161132812%
Volume Distribution (VD):  0.356
Pgp-substrate:  1.2974603176116943%

ADMET: Metabolism

CYP1A2-inhibitor:  0.481
CYP1A2-substrate:  0.033
CYP2C19-inhibitor:  0.187
CYP2C19-substrate:  0.04
CYP2C9-inhibitor:  0.872
CYP2C9-substrate:  0.772
CYP2D6-inhibitor:  0.197
CYP2D6-substrate:  0.19
CYP3A4-inhibitor:  0.412
CYP3A4-substrate:  0.11

ADMET: Excretion

Clearance (CL):  5.462
Half-life (T1/2):  0.968

ADMET: Toxicity

hERG Blockers:  0.096
Human Hepatotoxicity (H-HT):  0.325
Drug-inuced Liver Injury (DILI):  0.95
AMES Toxicity:  0.092
Rat Oral Acute Toxicity:  0.008
Maximum Recommended Daily Dose:  0.165
Skin Sensitization:  0.92
Carcinogencity:  0.18
Eye Corrosion:  0.003
Eye Irritation:  0.043
Respiratory Toxicity:  0.008

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473275

Natural Product ID:  NPC473275
Common Name*:   Feruloylpodospermic Acid A
IUPAC Name:   (1R,3R,4R,5R)-1,3-bis[3-(3,4-dihydroxyphenyl)propanoyloxy]-4-hydroxy-5-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid
Synonyms:  
Standard InCHIKey:  XDEMNTIHYAATHM-XFSWUUJNSA-N
Standard InCHI:  InChI=1S/C35H36O15/c1-47-27-16-21(4-10-24(27)38)6-12-31(42)49-29-18-35(34(45)46,50-32(43)13-7-20-3-9-23(37)26(40)15-20)17-28(33(29)44)48-30(41)11-5-19-2-8-22(36)25(39)14-19/h2-4,6,8-10,12,14-16,28-29,33,36-40,44H,5,7,11,13,17-18H2,1H3,(H,45,46)/b12-6+/t28-,29-,33-,35-/m1/s1
SMILES:  COc1cc(/C=C/C(=O)O[C@@H]2C[C@](OC(=O)CCc3ccc(c(c3)O)O)(C[C@H]([C@H]2O)OC(=O)CCc2ccc(c(c2)O)O)C(=O)O)ccc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL390314
PubChem CID:   44424296
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000129] Alcohols and polyols
          • [CHEMONTID:0001292] Cyclic alcohols and derivatives
            • [CHEMONTID:0002509] Cyclitols and derivatives
              • [CHEMONTID:0002512] Quinic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13478 Scorzonera pseudodivaricata Species Asteraceae Eukaryota n.a. Mongolian n.a. PMID[17542634]
NPO26200 Scorzonera divaricata Species Asteraceae Eukaryota n.a. Mongolian n.a. PMID[17542634]
NPO13478 Scorzonera pseudodivaricata Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26200 Scorzonera divaricata Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity IC50 = 36360000.0 nM PMID[487589]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473275 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470896
0.9404 High Similarity NPC146277
0.9404 High Similarity NPC19380
0.9338 High Similarity NPC93498
0.9338 High Similarity NPC163883
0.9324 High Similarity NPC98356
0.9257 High Similarity NPC477333
0.92 High Similarity NPC471076
0.92 High Similarity NPC192568
0.9156 High Similarity NPC145425
0.9145 High Similarity NPC477334
0.9122 High Similarity NPC472016
0.9122 High Similarity NPC303090
0.9122 High Similarity NPC319628
0.9122 High Similarity NPC277315
0.9122 High Similarity NPC37331
0.9122 High Similarity NPC284948
0.9122 High Similarity NPC258469
0.9122 High Similarity NPC43158
0.9122 High Similarity NPC220664
0.9122 High Similarity NPC192831
0.9114 High Similarity NPC227297
0.9091 High Similarity NPC469888
0.9054 High Similarity NPC471027
0.9054 High Similarity NPC477335
0.9054 High Similarity NPC224389
0.9054 High Similarity NPC297517
0.9054 High Similarity NPC13818
0.9054 High Similarity NPC35702
0.9054 High Similarity NPC206095
0.9045 High Similarity NPC476373
0.9026 High Similarity NPC44730
0.902 High Similarity NPC300329
0.9 High Similarity NPC471823
0.8957 High Similarity NPC476374
0.8954 High Similarity NPC221091
0.8954 High Similarity NPC259576
0.8944 High Similarity NPC128403
0.8933 High Similarity NPC160378
0.8931 High Similarity NPC476372
0.8931 High Similarity NPC476371
0.8919 High Similarity NPC205751
0.8919 High Similarity NPC295492
0.8919 High Similarity NPC274891
0.8919 High Similarity NPC474875
0.8919 High Similarity NPC288452
0.8919 High Similarity NPC476819
0.8919 High Similarity NPC476820
0.8919 High Similarity NPC26241
0.8919 High Similarity NPC289690
0.8919 High Similarity NPC303683
0.8896 High Similarity NPC476370
0.8882 High Similarity NPC322660
0.8882 High Similarity NPC143892
0.8882 High Similarity NPC299090
0.8882 High Similarity NPC221383
0.8882 High Similarity NPC283081
0.8874 High Similarity NPC143120
0.8874 High Similarity NPC473909
0.8874 High Similarity NPC274960
0.8851 High Similarity NPC152942
0.8851 High Similarity NPC302857
0.8851 High Similarity NPC37250
0.8851 High Similarity NPC219428
0.8851 High Similarity NPC142703
0.8851 High Similarity NPC278068
0.8851 High Similarity NPC24295
0.8851 High Similarity NPC283560
0.8839 High Similarity NPC246566
0.8839 High Similarity NPC95498
0.8831 High Similarity NPC306343
0.8824 High Similarity NPC472969
0.8774 High Similarity NPC252979
0.8774 High Similarity NPC243891
0.8766 High Similarity NPC98809
0.8766 High Similarity NPC476394
0.8766 High Similarity NPC42464
0.8766 High Similarity NPC475250
0.875 High Similarity NPC53884
0.875 High Similarity NPC258671
0.8734 High Similarity NPC134925
0.8718 High Similarity NPC267091
0.8718 High Similarity NPC75695
0.8718 High Similarity NPC476434
0.8701 High Similarity NPC43123
0.8701 High Similarity NPC98009
0.8688 High Similarity NPC53889
0.8684 High Similarity NPC304956
0.8679 High Similarity NPC133984
0.8679 High Similarity NPC226759
0.8671 High Similarity NPC131532
0.8659 High Similarity NPC216403
0.8659 High Similarity NPC41494
0.8659 High Similarity NPC186100
0.8649 High Similarity NPC70680
0.8649 High Similarity NPC233350
0.8649 High Similarity NPC182217
0.8645 High Similarity NPC478242
0.8642 High Similarity NPC173729
0.8642 High Similarity NPC134047
0.8642 High Similarity NPC272750
0.8642 High Similarity NPC223006
0.8625 High Similarity NPC87317
0.8625 High Similarity NPC469654
0.8608 High Similarity NPC477299
0.86 High Similarity NPC284409
0.859 High Similarity NPC473091
0.8589 High Similarity NPC142614
0.8581 High Similarity NPC135127
0.8581 High Similarity NPC68517
0.858 High Similarity NPC144557
0.858 High Similarity NPC285108
0.858 High Similarity NPC33298
0.8571 High Similarity NPC24164
0.8571 High Similarity NPC301089
0.8571 High Similarity NPC44507
0.8562 High Similarity NPC289322
0.8562 High Similarity NPC156818
0.8562 High Similarity NPC40920
0.8562 High Similarity NPC472860
0.8562 High Similarity NPC223335
0.8562 High Similarity NPC68324
0.8562 High Similarity NPC160512
0.8562 High Similarity NPC38779
0.8562 High Similarity NPC114179
0.8562 High Similarity NPC473090
0.8554 High Similarity NPC5786
0.8554 High Similarity NPC102851
0.8553 High Similarity NPC38699
0.8545 High Similarity NPC280493
0.8545 High Similarity NPC658
0.8545 High Similarity NPC197708
0.8544 High Similarity NPC327225
0.8528 High Similarity NPC45943
0.8521 High Similarity NPC108191
0.8521 High Similarity NPC93685
0.8516 High Similarity NPC229264
0.8514 High Similarity NPC475468
0.8514 High Similarity NPC155209
0.8514 High Similarity NPC168799
0.8506 High Similarity NPC469683
0.85 High Similarity NPC88803
0.85 High Similarity NPC104983
0.85 High Similarity NPC471405
0.85 High Similarity NPC291948
0.85 High Similarity NPC250436
0.85 High Similarity NPC300845
0.8494 Intermediate Similarity NPC472803
0.8494 Intermediate Similarity NPC180768
0.8494 Intermediate Similarity NPC476365
0.8491 Intermediate Similarity NPC194095
0.8491 Intermediate Similarity NPC327032
0.8491 Intermediate Similarity NPC191046
0.848 Intermediate Similarity NPC470416
0.8476 Intermediate Similarity NPC471788
0.8466 Intermediate Similarity NPC90905
0.8466 Intermediate Similarity NPC4013
0.8462 Intermediate Similarity NPC142528
0.8462 Intermediate Similarity NPC252402
0.8462 Intermediate Similarity NPC102934
0.8462 Intermediate Similarity NPC1580
0.8457 Intermediate Similarity NPC289346
0.8457 Intermediate Similarity NPC24627
0.8457 Intermediate Similarity NPC203020
0.8457 Intermediate Similarity NPC239966
0.8456 Intermediate Similarity NPC471110
0.8452 Intermediate Similarity NPC287495
0.8452 Intermediate Similarity NPC473630
0.8452 Intermediate Similarity NPC9370
0.8446 Intermediate Similarity NPC61
0.8446 Intermediate Similarity NPC25581
0.8446 Intermediate Similarity NPC18074
0.8446 Intermediate Similarity NPC5419
0.8442 Intermediate Similarity NPC114242
0.8442 Intermediate Similarity NPC50221
0.8442 Intermediate Similarity NPC469615
0.8438 Intermediate Similarity NPC203757
0.8438 Intermediate Similarity NPC10205
0.8434 Intermediate Similarity NPC266545
0.8434 Intermediate Similarity NPC202428
0.8434 Intermediate Similarity NPC95421
0.8434 Intermediate Similarity NPC198125
0.8431 Intermediate Similarity NPC31751
0.8431 Intermediate Similarity NPC67467
0.8431 Intermediate Similarity NPC253722
0.8431 Intermediate Similarity NPC253481
0.843 Intermediate Similarity NPC474093
0.843 Intermediate Similarity NPC104910
0.8421 Intermediate Similarity NPC110699
0.8421 Intermediate Similarity NPC36138
0.8421 Intermediate Similarity NPC179505
0.8421 Intermediate Similarity NPC322021
0.8421 Intermediate Similarity NPC106055
0.8421 Intermediate Similarity NPC156709
0.8415 Intermediate Similarity NPC291977
0.8411 Intermediate Similarity NPC126206
0.8405 Intermediate Similarity NPC311803
0.8405 Intermediate Similarity NPC472859
0.8405 Intermediate Similarity NPC25389
0.8405 Intermediate Similarity NPC216916

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473275 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9122 High Similarity NPD6190 Approved
0.8521 High Similarity NPD8055 Clinical (unspecified phase)
0.85 High Similarity NPD4868 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD6166 Phase 2
0.8235 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD7685 Pre-registration
0.8098 Intermediate Similarity NPD3817 Phase 2
0.8049 Intermediate Similarity NPD3882 Suspended
0.8038 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD7808 Phase 3
0.8013 Intermediate Similarity NPD6233 Phase 2
0.8 Intermediate Similarity NPD5844 Phase 1
0.8 Intermediate Similarity NPD7266 Discontinued
0.7966 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD7251 Discontinued
0.7955 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD2801 Approved
0.7907 Intermediate Similarity NPD6797 Phase 2
0.7895 Intermediate Similarity NPD7054 Approved
0.7892 Intermediate Similarity NPD7075 Discontinued
0.7879 Intermediate Similarity NPD5402 Approved
0.7866 Intermediate Similarity NPD1934 Approved
0.7849 Intermediate Similarity NPD7074 Phase 3
0.7849 Intermediate Similarity NPD7472 Approved
0.7844 Intermediate Similarity NPD6234 Discontinued
0.7836 Intermediate Similarity NPD7228 Approved
0.7836 Intermediate Similarity NPD3818 Discontinued
0.7811 Intermediate Similarity NPD6232 Discontinued
0.7792 Intermediate Similarity NPD230 Phase 1
0.7778 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7473 Discontinued
0.7765 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD3027 Phase 3
0.7758 Intermediate Similarity NPD37 Approved
0.7751 Intermediate Similarity NPD8127 Discontinued
0.7736 Intermediate Similarity NPD4628 Phase 3
0.7733 Intermediate Similarity NPD3751 Discontinued
0.7725 Intermediate Similarity NPD4965 Approved
0.7725 Intermediate Similarity NPD4967 Phase 2
0.7725 Intermediate Similarity NPD4966 Approved
0.7712 Intermediate Similarity NPD6798 Discontinued
0.7711 Intermediate Similarity NPD1465 Phase 2
0.7711 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD3787 Discontinued
0.7651 Intermediate Similarity NPD6801 Discontinued
0.7647 Intermediate Similarity NPD7199 Phase 2
0.7636 Intermediate Similarity NPD4380 Phase 2
0.7625 Intermediate Similarity NPD8166 Discontinued
0.7622 Intermediate Similarity NPD1653 Approved
0.7607 Intermediate Similarity NPD1512 Approved
0.76 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD6799 Approved
0.7586 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD5403 Approved
0.7542 Intermediate Similarity NPD8434 Phase 2
0.7532 Intermediate Similarity NPD7095 Approved
0.7516 Intermediate Similarity NPD9494 Approved
0.75 Intermediate Similarity NPD8455 Phase 2
0.7485 Intermediate Similarity NPD1511 Approved
0.7485 Intermediate Similarity NPD6386 Approved
0.7485 Intermediate Similarity NPD6385 Approved
0.7484 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6355 Discontinued
0.7447 Intermediate Similarity NPD7435 Discontinued
0.7444 Intermediate Similarity NPD8150 Discontinued
0.7439 Intermediate Similarity NPD5401 Approved
0.7412 Intermediate Similarity NPD7768 Phase 2
0.7396 Intermediate Similarity NPD7819 Suspended
0.7389 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD1613 Approved
0.7384 Intermediate Similarity NPD5494 Approved
0.7381 Intermediate Similarity NPD7411 Suspended
0.7374 Intermediate Similarity NPD8313 Approved
0.7374 Intermediate Similarity NPD8312 Approved
0.736 Intermediate Similarity NPD7240 Approved
0.7353 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD4062 Phase 3
0.7321 Intermediate Similarity NPD6599 Discontinued
0.7314 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7306 Intermediate Similarity NPD7874 Approved
0.7306 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD2935 Discontinued
0.7263 Intermediate Similarity NPD7039 Approved
0.7263 Intermediate Similarity NPD7038 Approved
0.7261 Intermediate Similarity NPD3764 Approved
0.7251 Intermediate Similarity NPD5353 Approved
0.725 Intermediate Similarity NPD7097 Phase 1
0.7229 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7870 Phase 2
0.7225 Intermediate Similarity NPD7871 Phase 2
0.7219 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD7033 Discontinued
0.7196 Intermediate Similarity NPD6778 Approved
0.7196 Intermediate Similarity NPD6776 Approved
0.7196 Intermediate Similarity NPD6777 Approved
0.7196 Intermediate Similarity NPD6782 Approved
0.7196 Intermediate Similarity NPD6779 Approved
0.7196 Intermediate Similarity NPD6780 Approved
0.7196 Intermediate Similarity NPD6781 Approved
0.7173 Intermediate Similarity NPD7697 Approved
0.7173 Intermediate Similarity NPD7698 Approved
0.7173 Intermediate Similarity NPD7696 Phase 3
0.7173 Intermediate Similarity NPD7680 Approved
0.717 Intermediate Similarity NPD4060 Phase 1
0.7167 Intermediate Similarity NPD6559 Discontinued
0.716 Intermediate Similarity NPD7458 Discontinued
0.7159 Intermediate Similarity NPD5242 Approved
0.7143 Intermediate Similarity NPD6959 Discontinued
0.7134 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5536 Phase 2
0.7126 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD919 Approved
0.7126 Intermediate Similarity NPD3146 Approved
0.7125 Intermediate Similarity NPD4340 Discontinued
0.7125 Intermediate Similarity NPD447 Suspended
0.7113 Intermediate Similarity NPD7701 Phase 2
0.7099 Intermediate Similarity NPD1510 Phase 2
0.7091 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD4110 Phase 3
0.7091 Intermediate Similarity NPD3750 Approved
0.7086 Intermediate Similarity NPD9545 Approved
0.7083 Intermediate Similarity NPD6273 Approved
0.7078 Intermediate Similarity NPD9269 Phase 2
0.7078 Intermediate Similarity NPD1608 Approved
0.7077 Intermediate Similarity NPD8151 Discontinued
0.7073 Intermediate Similarity NPD1549 Phase 2
0.7073 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD3749 Approved
0.7062 Intermediate Similarity NPD3926 Phase 2
0.7059 Intermediate Similarity NPD3455 Phase 2
0.7053 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD3887 Approved
0.7048 Intermediate Similarity NPD2354 Approved
0.7047 Intermediate Similarity NPD8319 Approved
0.7047 Intermediate Similarity NPD8320 Phase 1
0.7045 Intermediate Similarity NPD1247 Approved
0.7033 Intermediate Similarity NPD7549 Discontinued
0.703 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7229 Phase 3
0.7005 Intermediate Similarity NPD7801 Approved
0.7 Intermediate Similarity NPD7699 Phase 2
0.7 Intermediate Similarity NPD7700 Phase 2
0.6979 Remote Similarity NPD2494 Approved
0.6979 Remote Similarity NPD2493 Approved
0.6975 Remote Similarity NPD6653 Approved
0.697 Remote Similarity NPD4534 Discontinued
0.6964 Remote Similarity NPD4357 Discontinued
0.6959 Remote Similarity NPD228 Approved
0.6959 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6959 Remote Similarity NPD3226 Approved
0.6957 Remote Similarity NPD1240 Approved
0.6957 Remote Similarity NPD943 Approved
0.6957 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2796 Approved
0.6931 Remote Similarity NPD6534 Approved
0.6931 Remote Similarity NPD6535 Approved
0.6923 Remote Similarity NPD2534 Approved
0.6923 Remote Similarity NPD2533 Approved
0.6923 Remote Similarity NPD2532 Approved
0.6923 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6919 Remote Similarity NPD7783 Phase 2
0.6919 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6918 Remote Similarity NPD4908 Phase 1
0.6909 Remote Similarity NPD5762 Approved
0.6909 Remote Similarity NPD5763 Approved
0.6905 Remote Similarity NPD7440 Discontinued
0.6903 Remote Similarity NPD1535 Discovery
0.6891 Remote Similarity NPD3452 Approved
0.6891 Remote Similarity NPD3450 Approved
0.6886 Remote Similarity NPD7003 Approved
0.6886 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6883 Remote Similarity NPD17 Approved
0.6882 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6879 Remote Similarity NPD3225 Approved
0.6879 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6971 Discontinued
0.6872 Remote Similarity NPD4582 Approved
0.6872 Remote Similarity NPD4583 Approved
0.6871 Remote Similarity NPD1607 Approved
0.6867 Remote Similarity NPD5958 Discontinued
0.6859 Remote Similarity NPD1481 Phase 2
0.6856 Remote Similarity NPD6823 Phase 2
0.6852 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6852 Remote Similarity NPD3620 Phase 2
0.6848 Remote Similarity NPD6100 Approved
0.6848 Remote Similarity NPD6099 Approved
0.6848 Remote Similarity NPD1551 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data